Women receive a greater clinical benefit from cardiac resynchronization therapy defibrillators (CRT-Ds) than men, according to a gender-based sub-analysis of the MADIT-CRT trial data published in the current issue of the Journal of American College of Cardiology (Washington). (Medical Device Daily)